Bladder Dysfunction

The FDA announced that it has approved Astellas Pharma’s VESIcare LS oral suspension for the treatment of neurogenic detrusor overactivity, or NDO, in children aged 2 years and older.

Children with more than one febrile UTI are at a significantly increased risk for kidney scarring, according to findings published in JAMA Pediatrics. Researchers wrote that the risk for scarring increases with each additional febrile infection.